Von Eschenbach wants to be which McClellan?
Executive Summary
During a recent panel discussion with former CMS Administrator Mark McClellan, FDA Commissioner Andrew von Eschenbach said he "would like to do what McClellan is doing" when he leaves his current post at the end of the Bush Administration. After hearing murmurs from the crowd at the American Society of Health Economists meeting at Duke University, von Eschenbach clarified, "Not that McClellan, this McClellan," he adds. Mark McClellan, who previously headed FDA as well as CMS, now is senior fellow and director of the Engelberg Center for Health Care Reform at the Brookings Institution. McClellan's brother Scott has made news with his new memoir critical of the Bush administration during his tenure as White House press secretary
You may also be interested in...
Building the Right Foundation: An Interview with Mark McClellan
The Reagan-Udall Foundation is an early priority for FDA in implementing the landmark legislation enacted by Congress in 2007. It is also a lightning road for criticism from Congress about the agency's relationship with regulated industry. We asked foundation chairman Mark McClellan for a status report.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.